<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>3 Healthcare Stocks We’re Skeptical Of — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">3 Healthcare Stocks We’re Skeptical Of</h2>
    <div class="badge">2025-09-08T04:33:51+00:00</div>
    <ul>
      <li>- Revenue base of $1.28 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale - Low free cash flow margin of 4% for the last five years gives it little breathing room, constrainin</li>
<li>- Customers postponed purchases of its products and services this cycle as its revenue declined by 2.9% annually over the last two years - Organic revenue growth fell short of our benchmarks over the past two years and i</li>
<li>Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 1.4% gain for healthcare stocks has fallen</li>
<li>Penumbra (PEN) Market Cap: $10.98 billion Founded in 2004 to address challenging medical conditions with significant unmet needs, Penumbra (NYSE:PEN) develops and manufactures innovative medical devices for treating vasc</li>
<li>Hologic (HOLX) Market Cap: $14.85 billion As a pioneer in 3D mammography technology that has revolutionized breast cancer detection, Hologic (NASDAQ:HOLX) develops and manufactures diagnostic products, medical imaging sy</li>
<li>Danaher (DHR) Market Cap: $143.4 billion Born from a real estate investment trust that transformed into a manufacturing powerhouse, Danaher (NYSE:DHR) is a global science and technology company that provides specialized</li>
<li>Why Does PEN Worry Us?</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=3%20Healthcare%20Stocks%20We%E2%80%99re%20Skeptical%20Of%0A%E2%80%A2%20Revenue%20base%20of%20%241.28%20billion%20puts%20it%20at%20a%20disadvantage%20compared%20to%20larger%20competitors%20exhibiting%20economies%20of%20scale%20-%20Low%20free%20cash%20flow%20margin%20of%204%25%20for%20the%20last%20five%20years%20gives%20it%20little%20breathing%20room%2C%20constrainin%0A%E2%80%A2%20Customers%20postponed%20purchases%20of%20its%20products%20and%20services%20this%20cycle%20as%20its%20revenue%20declined%20by%202.9%25%20annually%20over%20the%20last%20two%20years%20-%20Organic%20revenue%20growth%20fell%20short%20of%20our%20benchmarks%20over%20the%20past%20two%20years%20and%20i%0A%E2%80%A2%20Despite%20the%20rosy%20long-term%20prospects%2C%20short-term%20headwinds%20such%20as%20COVID%20inventory%20destocking%20have%20caused%20the%20industry%20to%20lag%20recently%20-%20over%20the%20past%20six%20months%2C%20the%20collective%201.4%25%20gain%20for%20healthcare%20stocks%20has%20fallen%0A%E2%80%A2%20Penumbra%20%28PEN%29%20Market%20Cap%3A%20%2410.98%20billion%20Founded%20in%202004%20to%20address%20challenging%20medical%20conditions%20with%20significant%20unmet%20needs%2C%20Penumbra%20%28NYSE%3APEN%29%20develops%20and%20manufactures%20innovative%20medical%20devices%20for%20treating%20vasc%0A%E2%80%A2%20Hologic%20%28HOLX%29%20Market%20Cap%3A%20%2414.85%20billion%20As%20a%20pioneer%20in%203D%20mammography%20technology%20that%20has%20revolutionized%20breast%20cancer%20detection%2C%20Hologic%20%28NASDAQ%3AHOLX%29%20develops%20and%20manufactures%20diagnostic%20products%2C%20medical%20imaging%20sy%0A%E2%80%A2%20Danaher%20%28DHR%29%20Market%20Cap%3A%20%24143.4%20billion%20Born%20from%20a%20real%20estate%20investment%20trust%20that%20transformed%20into%20a%20manufacturing%20powerhouse%2C%20Danaher%20%28NYSE%3ADHR%29%20is%20a%20global%20science%20and%20technology%20company%20that%20provides%20specialized%0A%E2%80%A2%20Why%20Does%20PEN%20Worry%20Us%3F&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2F3-healthcare-stocks-we-re-skeptical-of%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/3-healthcare-stocks-skeptical-043351121.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>